Zeticalm 1 Tablet contains Etizolam 1mg, a thienodiazepine derivative with anxiolytic, sedative, and muscle relaxant properties. It is primarily indicated for the short-term management of anxiety disorders, panic attacks, and insomnia associated with anxiety. Etizolam acts on the central nervous system by enhancing the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor, producing a calming effect. This medication is typically prescribed when non-pharmacological interventions are insufficient or when rapid symptom relief is necessary. Zeticalm should be used at the lowest effective dose for the shortest duration to minimize the risk of dependence, tolerance, and withdrawal symptoms. Common adverse effects include drowsiness, dizziness, and impaired coordination, which may affect activities requiring alertness such as driving. Caution is advised in patients with a history of substance abuse, respiratory insufficiency, or hepatic impairment. Concomitant use with other central nervous system depressants, including alcohol, should be avoided due to the potential for additive sedation and respiratory depression. Zeticalm is contraindicated in individuals with hypersensitivity to Etizolam or benzodiazepine derivatives. Patients should follow the prescribed dosage regimen and consult their healthcare provider before discontinuation to prevent rebound anxiety or withdrawal phenomena.